OA08796A - Composition de sels et d'ion amphotèrine lyophylisée ou précipitée. - Google Patents

Composition de sels et d'ion amphotèrine lyophylisée ou précipitée.

Info

Publication number
OA08796A
OA08796A OA59260A OA59260A OA08796A OA 08796 A OA08796 A OA 08796A OA 59260 A OA59260 A OA 59260A OA 59260 A OA59260 A OA 59260A OA 08796 A OA08796 A OA 08796A
Authority
OA
OAPI
Prior art keywords
amphoterin
lyophilized
precipitated
salts
ion
Prior art date
Application number
OA59260A
Other languages
English (en)
French (fr)
Inventor
Murray Arthur Kaplan
Oseph Ballard Bogardus
Nageswara R Palepu
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of OA08796A publication Critical patent/OA08796A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
OA59260A 1987-01-09 1988-01-08 Composition de sels et d'ion amphotèrine lyophylisée ou précipitée. OA08796A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/001,945 US4808617A (en) 1985-12-18 1987-01-09 Lyophilized or precipitated cephalosporin zwitterion and salt combination

Publications (1)

Publication Number Publication Date
OA08796A true OA08796A (fr) 1989-03-31

Family

ID=21698538

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59260A OA08796A (fr) 1987-01-09 1988-01-08 Composition de sels et d'ion amphotèrine lyophylisée ou précipitée.

Country Status (33)

Country Link
US (1) US4808617A (pt)
JP (1) JP2568226B2 (pt)
KR (1) KR950010154B1 (pt)
AR (1) AR243501A1 (pt)
AT (1) AT388672B (pt)
AU (1) AU606361B2 (pt)
BE (1) BE1002114A3 (pt)
CA (1) CA1307464C (pt)
CH (1) CH676202A5 (pt)
CS (1) CS265249B2 (pt)
CY (1) CY1679A (pt)
DD (1) DD264614A5 (pt)
DE (1) DE3740588C2 (pt)
DK (1) DK166404B1 (pt)
ES (1) ES2008951A6 (pt)
FI (1) FI89006C (pt)
FR (1) FR2609396B1 (pt)
GB (1) GB2199746B (pt)
GR (1) GR871860B (pt)
HK (1) HK5593A (pt)
HU (1) HU199686B (pt)
IE (1) IE61238B1 (pt)
IL (1) IL84346A (pt)
IT (1) IT1215666B (pt)
LU (1) LU87102A1 (pt)
NL (1) NL193266C (pt)
OA (1) OA08796A (pt)
PT (1) PT86157B (pt)
SE (1) SE467910B (pt)
SG (1) SG114792G (pt)
SU (1) SU1575942A3 (pt)
YU (1) YU46689B (pt)
ZA (1) ZA88114B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO2005094800A2 (en) * 2004-03-31 2005-10-13 Lupin Ltd. A co-precipitated cefepime composition and process for preparation thereof
WO2006109324A2 (en) * 2005-04-13 2006-10-19 Lupin Limited Processes for preparation of amorphous cefepime acid addition salts
JP5491119B2 (ja) * 2009-10-02 2014-05-14 日東電工株式会社 薬物含有微粒子を含む医薬組成物およびその製造方法
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
MX2020004205A (es) 2013-03-15 2021-11-16 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano.
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101935186B1 (ko) 2014-09-04 2019-01-03 시오노기세야쿠 가부시키가이샤 카테콜기를 갖는 세팔로스포린류를 함유하는 제제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953439A (en) * 1973-08-01 1976-04-27 Smithkline Corporation Substituted phenylglycylcephalosporins
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
CA1213882A (en) * 1982-03-04 1986-11-12 Jun Okumura Cephalosporins
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4604386A (en) * 1984-07-09 1986-08-05 Eli Lilly And Company 3-(alkynylalkyloxy) cephalosporins
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤
CA1284994C (en) * 1985-08-05 1991-06-18 Murray Arthur Kaplan Cephalosporin salts and injectable compositions

Also Published As

Publication number Publication date
NL193266C (nl) 1999-05-06
GR871860B (en) 1988-05-10
AU606361B2 (en) 1991-02-07
DK166404B1 (da) 1993-05-17
PT86157B (pt) 1991-02-08
CH676202A5 (pt) 1990-12-28
IT8819013A0 (it) 1988-01-07
AU8085687A (en) 1989-05-11
DD264614A5 (de) 1989-02-08
CS15888A2 (en) 1989-01-12
BE1002114A3 (fr) 1990-07-10
IE61238B1 (en) 1994-10-19
CS265249B2 (en) 1989-10-13
JP2568226B2 (ja) 1996-12-25
IT1215666B (it) 1990-02-22
FI89006C (fi) 1993-08-10
CA1307464C (en) 1992-09-15
ZA88114B (pt) 1988-06-27
ES2008951A6 (es) 1989-08-16
KR880008811A (ko) 1988-09-13
DE3740588C2 (de) 1996-07-11
GB8725875D0 (en) 1987-12-09
HUT46223A (en) 1988-10-28
YU2388A (en) 1989-10-31
CY1679A (en) 1993-10-10
FR2609396A1 (fr) 1988-07-15
HK5593A (en) 1993-02-05
NL193266B (nl) 1999-01-04
AT388672B (de) 1989-08-10
HU199686B (en) 1990-03-28
SG114792G (en) 1992-12-24
SE8800036L (sv) 1988-07-10
NL8800025A (nl) 1988-08-01
GB2199746B (en) 1990-10-24
YU46689B (sh) 1994-04-05
US4808617A (en) 1989-02-28
PT86157A (en) 1987-12-01
JPS63208522A (ja) 1988-08-30
IE872970L (en) 1988-07-09
KR950010154B1 (ko) 1995-09-11
DK577387D0 (da) 1987-11-03
SE467910B (sv) 1992-10-05
IL84346A (en) 1992-05-25
DK577387A (da) 1988-07-10
ATA341687A (de) 1989-01-15
FI875122A0 (fi) 1987-11-19
DE3740588A1 (de) 1988-07-21
IL84346A0 (en) 1988-04-29
LU87102A1 (fr) 1988-08-23
FI875122A (fi) 1988-07-10
AR243501A1 (es) 1993-08-31
FR2609396B1 (fr) 1993-01-29
SE8800036D0 (sv) 1988-01-08
GB2199746A (en) 1988-07-20
SU1575942A3 (ru) 1990-06-30
FI89006B (fi) 1993-04-30

Similar Documents

Publication Publication Date Title
PT86304A (pt) Recipiente classificador de secretaria ou similar
ES556600A0 (es) Procedimiento de obtencion de polimerizados por injerto solubles o dispersables en agua
ZA85206B (en) Protein conjugates useful in the treatment of thrombotic disease
OA08796A (fr) Composition de sels et d'ion amphotèrine lyophylisée ou précipitée.
BR8702978A (pt) Aplicacao de 3-acilamino-1,2,4-triazois e/ou de 1-acil-3-amino-1,2,4-triazois
LU90240I2 (fr) Tilmicosine et les sels d'addition d'acide de celle-ci (micotil r)
DK420785A (da) 13-halogen- eller 13-hydroxymilbemyciner samt deres fremstilling og anvendelse
BR8707454A (pt) Gel po's-espumante contendo determinada dialcanolamida ou monoalcanolamida
GB2208310B (en) Improvements in or relating to the identification of pipeline sections
FR2617502B1 (fr) Preparation enzymatique d'anhydro-1,5 d fructose
DK497088A (da) Vandoploeselige polysakkarider samt fremstilling og anvendelse deraf
IT1188092B (it) Pigmento di opacita' o di imbianchimento e procedimento di preparazione
DK320288D0 (da) Sakkaroaskorbinsyreestere samt fremstilling og anvendelse deraf
FR2610521B1 (fr) Nouvelles compositions cosmetiques presentant une substantivite et/ou une adherence ameliorees
DK24185D0 (da) N-phosphoryl- eller n-thiophosphoryl-n'-s-triazinyl-formamidiner samt deres fremstilling og anvendelse
BR9002945A (pt) Conjunto estrutural de relacionar informacoes e/ou estimulos
FR2557833B1 (fr) Parapheur ou trieur de courrier
DE3574708D1 (de) Stereoisomerisch reines 17-alpha-ethynyl-est-2-en-17beta-ol und dessen ester.
FR2571309B2 (fr) Parapheur ou trieur de courrier
IT8702935A0 (it) Comando d'apertura e chiusura di tettucci per veicoli.
KR890006776U (ko) 차량의 2음향 방향지시기
BR6901044U (pt) Brinquedo e/ou adorno
IT8420738V0 (it) Sistema d'incernieramento rototraslativo di antine di mobili in genere.
BR8802419A (pt) Sistema para cultura de lagostas de tipo"panulirus argus"(letreille)sem inconvenientes canibalisticos
BR6701736U (pt) Sistema anti-aspiracao aplicado em bocal de zabatana e/ou objetos de sopro